Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00143065 · COMPLETED
Trial details
- NCT number
- NCT00143065
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-02-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.